Trials based on the findings of the SPREE study showed that a mini-combined method using maternal history, MAP, UtA-PI, and PAPP-A instead of PLGF, typically recorded during routine first-trimester screening, showed comparable efficacy to the full model in predicting preeclampsia. This evidence concerns the gene PGF and preeclampsia.